263 related articles for article (PubMed ID: 26963912)
1. Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study.
Kim SW; Jhon M; Kim JM; Smesny S; Rice S; Berk M; Klier CM; McGorry PD; Schäfer MR; Amminger GP
PLoS One; 2016; 11(3):e0151417. PubMed ID: 26963912
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.
Berger M; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Mitchell TW; Meyer BJ; Thompson A; Yung AR; McGorry PD; Amminger GP
Front Psychiatry; 2019; 10():393. PubMed ID: 31244693
[No Abstract] [Full Text] [Related]
3. Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis.
Kim SW; Schäfer MR; Klier CM; Berk M; Rice S; Allott K; Bartholomeusz CF; Whittle SL; Pilioussis E; Pantelis C; McGorry PD; Amminger GP
Schizophr Res; 2014 Sep; 158(1-3):39-44. PubMed ID: 25066495
[TBL] [Abstract][Full Text] [Related]
4. Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.
Amminger GP; Mechelli A; Rice S; Kim SW; Klier CM; McNamara RK; Berk M; McGorry PD; Schäfer MR
Transl Psychiatry; 2015 Jan; 5(1):e495. PubMed ID: 25585167
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.
Smesny S; Milleit B; Hipler UC; Milleit C; Schäfer MR; Klier CM; Holub M; Holzer I; Berger GE; Otto M; Nenadic I; Berk M; McGorry PD; Sauer H; Amminger GP
Mol Psychiatry; 2014 Mar; 19(3):317-24. PubMed ID: 23478748
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte polyunsaturated fatty acid levels in young people at ultra-high risk for psychotic disorder and healthy adolescent controls.
Rice SM; Schäfer MR; Klier C; Mossaheb N; Vijayakumar N; Amminger GP
Psychiatry Res; 2015 Jul; 228(1):174-6. PubMed ID: 25979466
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial.
Amminger GP; Chanen AM; Ohmann S; Klier CM; Mossaheb N; Bechdolf A; Nelson B; Thompson A; McGorry PD; Yung AR; Schäfer MR
Can J Psychiatry; 2013 Jul; 58(7):402-8. PubMed ID: 23870722
[TBL] [Abstract][Full Text] [Related]
8. Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study.
Berger ME; Smesny S; Kim SW; Davey CG; Rice S; Sarnyai Z; Schlögelhofer M; Schäfer MR; Berk M; McGorry PD; Amminger GP
Transl Psychiatry; 2017 Aug; 7(8):e1220. PubMed ID: 28850110
[TBL] [Abstract][Full Text] [Related]
9. Erythrocyte membrane fatty acid composition is related to overloaded plasma ferritin in Chinese males with angiographic coronary artery disease.
Li Z; Li X; Zhang Y; Feng X; Yang F; Su D; Qiu J; Ling W; Yang Y
Food Funct; 2013 Oct; 4(10):1535-42. PubMed ID: 24056314
[TBL] [Abstract][Full Text] [Related]
10. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group.
Assies J; Lieverse R; Vreken P; Wanders RJ; Dingemans PM; Linszen DH
Biol Psychiatry; 2001 Mar; 49(6):510-22. PubMed ID: 11257236
[TBL] [Abstract][Full Text] [Related]
11. Effect of omega-3 fatty acids on the modification of erythrocyte membrane fatty acid content including oleic acid in peritoneal dialysis patients.
An WS; Lee SM; Son YK; Kim SE; Kim KH; Han JY; Bae HR; Park Y
Prostaglandins Leukot Essent Fatty Acids; 2012; 86(1-2):29-34. PubMed ID: 22071008
[TBL] [Abstract][Full Text] [Related]
12. Erythrocytes and Skeletal Muscle Unsaturated and Omega-6 Fatty Acids Are Positively Correlated after Caloric Restriction and Exercise.
Martorell M; Pons V; Domingo JC; Capó X; Sureda A; Drobnic F; Tur JA; Pons A
Ann Nutr Metab; 2018; 72(2):126-133. PubMed ID: 29353271
[TBL] [Abstract][Full Text] [Related]
13. Correlates of electroencephalographic resting states and erythrocyte membrane docosahexaenoic and eicosapentaenoic acid levels in individuals at ultra-high risk of psychosis.
Lavoie S; Whitford TJ; Benninger F; Feucht M; Kim SW; Klier CM; McNamara RK; Rice S; Schäfer MR; Amminger GP
Aust N Z J Psychiatry; 2016 Jan; 50(1):56-63. PubMed ID: 25690743
[TBL] [Abstract][Full Text] [Related]
14. Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people.
Alqarni A; Mitchell TW; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Berger M; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Amminger GP; Meyer BJ
Schizophr Res; 2020 Dec; 226():44-51. PubMed ID: 31301881
[TBL] [Abstract][Full Text] [Related]
15. [Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?].
Frajerman A; Kebir O; Chaumette B; Tessier C; Lamazière A; Nuss P; Krebs MO
Encephale; 2020 Jun; 46(3):209-216. PubMed ID: 32151446
[TBL] [Abstract][Full Text] [Related]
16. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
[TBL] [Abstract][Full Text] [Related]
17. Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.
McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EY; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Amminger GP
JAMA Psychiatry; 2017 Jan; 74(1):19-27. PubMed ID: 27893018
[TBL] [Abstract][Full Text] [Related]
18. Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective?
Mossaheb N; Schäfer MR; Schlögelhofer M; Klier CM; Cotton SM; McGorry PD; Amminger GP
Schizophr Res; 2013 Aug; 148(1-3):163-7. PubMed ID: 23778032
[TBL] [Abstract][Full Text] [Related]
19. [Blood fatty acids in the development and correction of metabolic syndrome].
Novgorodtseva TP; Denisenko YK; Antonyuk MV; Yubitskaya NS; Lobanova EG; Zhukova NV
Ter Arkh; 2016; 88(8):30-34. PubMed ID: 27636924
[TBL] [Abstract][Full Text] [Related]
20. Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment.
Evans DR; Parikh VV; Khan MM; Coussons C; Buckley PF; Mahadik SP
Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):393-9. PubMed ID: 14623492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
